Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

Summary

The main objective of the trial is to demonstrate the efficacy of a two months pre-seasonal treatment with AllerT 100 µg maintenance dose in reducing symptoms of allergic rhinoconjunctivitis during the following birch pollen season

Timeline

Start

2012-10

Primary completion

2013-09

Completion

2013-09

Drugs

Indications